TD5A.F Tandem Diabetes Care Inc

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
15.80 EUR
Close of Nov 13, 2026
10.90 23.09
Market cap
EUR 1.10B
P/E
-
P/B
9.64x
ROE
-48.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is TD5A.F undervalued?

Graham number

The Graham number of Tandem Diabetes Care Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Tandem Diabetes Care Inc fundamental analysis

No fundamental analysis for Tandem Diabetes Care Inc yet.

Tandem Diabetes Care Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it …

Full company profile